Research Institute of Molecular Pathology

Research Institute of Molecular Pathology (IMP)
Established	1985
Research type	Basic (non-clinical); Life sciences;
Field of research	Molecular and Cellular Biology; Structural biology and biochemistry; Gene expression and chromosome biology; Stem cell biology and development; Immunology and cancer; Neuroscience;
Director	Jan-Michael Peters (science); Harald Isemann (administration)
Faculty	15
Staff	280
Address	Campus-Vienna-Biocenter 1, 1030 Vienna, Austria
Location	Vienna, Austria
Website	www.imp.ac.at

The Research Institute of Molecular Pathology (IMP) is a biomedical research center, which conducts curiosity-driven basic research in the molecular life sciences.

The IMP is located at the Vienna Biocenter in Vienna, Austria. The institute employs around 280 people from 40 countries, of which over 200 are scientists.^[1] The working language at the IMP is English. The IMP was established in 1985 and is funded by the pharmaceutical company Boehringer Ingelheim and research grants.^[2]

^ "IMP at a Glance". Retrieved 25 January 2019.
^ "The Research Institute of Molecular Pathology". boehringer-ingelheim.com. Retrieved 2018-02-18.

[1] "IMP at a Glance". Retrieved 25 January 2019.

[boehringer-ingelheim.com-2] "The Research Institute of Molecular Pathology". boehringer-ingelheim.com. Retrieved 2018-02-18.

[1]

[2]